Brokerage house Firstcall Research is bullish on Indoco Remedies and has recommended buy rating on the stock with a target price of Rs 365 in its research report dated February 18, 2015.

Angel Broking neutral on Indoco Remedies

Angel Broking has maintained a neutral rating on Indoco Remedies, in its February 02, 2015 research report.

Hold Indoco Remedies; target of Rs 274: ICICIdirect

ICICIdirect.com has recommended hold rating on Indoco Remedies with a target price of Rs 274, in its research report dated October 22, 2014.

Buy Indoco Remedies; target of Rs 349: P Lilladher

Brokerage house Prabhudas Lilladher is bullish on Indoco Remedies and has recommended 'Buy' rating on the stock with a target price of Rs 349 in its research report dated October 21, 2014.

Buy Indoco Remedies; target of Rs 330: Religare Capital

Brokerage house Religare Capital is bullish on Indoco Remedies and has recommended 'Buy' rating on the stock with a target price of Rs 330 in its research report dated October 21, 2014.

Angel Broking neutral on Indoco Remedies

Angel Broking has maintained a neutral rating on Indoco Remedies, in its May 29, 2014 research report.

Angel Broking neutral on Indoco Remedies

Brokerage house Angel Broking has maintained a 'Neutral' rating on Indoco Remedies in its October 31, 2013 research report.

Buy Indoco Remedies; target of Rs 86: AnandRathi

AnandRathi Securities is bullish on Indoco Remedies and has recommended buy rating on the stock with a target price of Rs 86 in its October 07, 2013 research report.

Hold Indoco Remedies; target of Rs 71: Firstcall Research

Brokerage house Firstcall Research has recommended hold rating on Indoco Remedies with a target price of Rs 71, in its September 18, 2013 research report.

Buy Indoco Remedies; target Rs 104: Nirmal Bang

Nirmal Bang is bullish on Indoco Remedies and has recommended buy rating on the stock with a price target of Rs 104, in its research report dated July 18, 2013.

Buy Indoco Remedies; target of Rs 78: Angel Broking

Angel Broking is bullish on Indoco Remedies and has recommended buy rating on the stock with a target of Rs 78 in its January 29, 2013 research report.

Buy Indoco Remedies; target of Rs 82: Angel Broking

Angel Broking is bullish on Indoco Remedies and has recommended buy rating on the stock with a target of Rs 82 in its July 30, 2012 research report.

Buy Indoco Remedies; target of Rs 82: Angel Broking

Angel Broking is bullish on Indoco Remedies and has recommended buy rating on the stock with a target of Rs 82 in its June 1, 2012 research report.

Buy Indoco Remedies for long term: Nirmal Bang

Nirmal Bang has come out with its report on Indoco Remedies. The research firm is positive on the company with a long term perspective.

Buy Indoco Remedies; target Rs 587: Sushil Finance

Sushil Finance is bullish on Indoco Remedies (IRL) and has recommended buy rating on the stock with a target of Rs 587 in its October 31, 2011 research report.

Buy Indoco Remedies; target of Rs 583: Angel Broking

Angel Broking is bullish on Indoco Remedies and has recommended buy rating on the stock with a target of Rs 583 in its October 28, 2011 research report.

Buy Indoco Remedies; target of Rs 665: Angel Broking

Angel Broking is bullish on Indoco Remedies and has recommended buy rating on the stock with a target of Rs 665 in its July 29, 2011 research report.

Buy Indoco Remedies; target of Rs 600: Hem Securities

Hem Securities is bullish on Indoco Remedies and has recommended buy rating on the stock with a target of Rs 600 in its May 21, 2011 research report.

Buy Indoco Remedies; target of Rs 587: Sushil Finance

Sushil Finance is bullish on Indoco Remedies and has recommended buy rating on the stock with a target of Rs 587 in its May 10, 2011 research report.

Buy Indoco Remedies; target of Rs 517: KRChoksey

KRChoksey is bullish on Indoco Remedies and has recommended buy rating on the stock with a target of Rs 517 in its April 11, 2011 research report.

Hold Indoco Remedies; target of Rs 516: KRChoksey

KRChoksey has recommended hold rating on Indoco Remedies with a target of Rs 516, in its March 14, 2011 research report.